The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic lineages. However, their ...

In the new Nature paper, the researchers describe a method of growing heart tissue from stem cells known as induced pluripotent stem cells (iPSCs). Scientists create these stem cells by gathering ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

Researchers have developed engineered heart muscle allografts from stem cells, showing promising results in repairing heart ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

Scientists have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as ...